Tumor mutations, translocations Flashcards
Follicular lymphoma
t(14;18) IGH-BCL2
Mantle cell lymphoma
t(11;14) CCND1-IGH
CLL/SLL
subset del 13q14.3 - Good prognosis
Burkitt lymphoma
t(8;14) MYC-IGHt(8;22) MYC-IGLt(2;8) MYC-IGK
Precursor B-ALL
t(4;11) MLL-AF4 (poor prognosis)t(9;22) BCR-ABL (poor prognosis)Hyperdiploidy (good prognosis)t(12;21) ETV6-RUNX1 (good prognosis)
Multiple myeloma
Complex karyotype - poor pxt(11;14) CCND1-IGH - good px
ALCL (ALK+)
t(2;5) NPM-ALKOther ALK rearrangements
Hepatosplenic T-cell lymphoma
Isochromosome 7q
Alveolar soft part sarcoma
t(X;17) ASPL-TFE3 *same as in translocation carcinoma of kidney
Angiomatoid fibrous histiocytoma
t(12;16) FUS/TLS-ATF1t(12;22) EWS-ATF1t(2;22) EWS-CREB1
Clear cell sarcoma
t(12;22) EWS-ATF1t(2;22) EWS-CREB1
DFSP
t(17;22) COL1A-PDGFbRing chromosome 17
Endometrial stromal sarcoma (low grade)
t(7;17) JAZF1-JJAZ1
Extraskeletal myxoid chondrosarcoma
t(9;22) EWS-CHNt(9;17) RBP56-CHN
Ewing sarcoma / PNET
t(11;22) EWS-FLI1t(21;22) EWS-ERG
GIST
c-Kit mutationPDGFRA mutation (epithelioid)
Inflammatory myofibroblastic tumor
t(2;5) NPM-ALKOther ALK rearrangements
Infantile fibrosarcoma
t(12;15) ETV6-NTRK3
Desmoplastic small round cell tumor
t(11;22) EWS-WT1
Myxoid / round cell liposarcoma
t(12;16) FUS-CHOPt(12;22) EWS-CHOP
Well-differentiated liposarcoma
Ring chromosome 12 - HMGA2, MDM amplification
Low grade fibromyxoid sarcoma
t(7;16) FUS-CREB3L2t(11;16) FUS-CREB3L1
Neuroblastoma
Hyperdiploidy (good prognosis)+17q (bad prognosis)N-myc amplification (bad prognosis)
PEComa
TFE3 rearrangements or amplification
Alveolar rhabdomyosarcoma
t(1;13) PAX7-FKHR (good prognosis)t(2;13) PAX3-FKHR (bad prognosis)
Embryonal rhabdomyosarcoma
Loss of 11p15 (as in Beckwith-Wiedeman syndrome)
Extrarenal rhabdoid tumor
22q11.2 deletion or mutation - INI-1
Seminoma
Isochromosome 12p
Synovial sarcoma
t(X;18) SYT-SSX1t(X;18) SYT-SSX2
Medulloblastoma
Isochromosome 17q
Oligodendroglioma
1p/19q deletion (loss of heterozygosity)
Atypical teratoid / rhabdoid tumor (AT/RT)
22q11.2 deletion or mutation - INI1
Retinoblastoma
13q14 deletion (Rb)
Meningioma
Monosomy 22
Pilocytic astrocytoma
7q34 duplication - BRAF-KIAA1549 fusion
Colorectal carcinoma
APC (80%)MMR pathway genes (15%)K-RAS (35%)
Lung adenocarcinoma
K-RASEGFREML4-ALK, RET, ROS
Papillary thyroid carcinoma
BRAF V600E (tall cell)RET-PTCNTRK1(Ras in follicular variant)
Follicular thyroid carcinoma
t(2;3) PAX8-PPARyRAS
Medullary thyroid carcinoma
RET
Clear cell renal cell carcinoma
3p deletion - VHL
Papillary renal cell carcinoma
Trisomy 7, 17Deletion YMET activation mutations
Translocation-associated renal cell carcinoma
t(X;17) ASPL-TFE3 (positive for TFE3 IHC)t(6;11) Alpha-TFEB (positive for TFEB IHC)
Skin melanoma
BRAF V600EN-RAS
NUT midline carcinoma
t(15;19) BRD4-NUTt(9;15) BRD3-NUT
Prostate cancer
21q22.2-3 deletion TMPRSS2-ERG
Mucoepidermoid carcinoma
t(11;19) MECT1-MAML2
Pleomorphic adenoma
PLAG1, HMG2A mutations
Secretory carcinoma
t(12;15) ETV6-NTRK3
Granulosa cell tumor, adult type
FOXL2 mutation
Biphenotypic sinonasal sarcoma
PAX3-MAML3
Uveal (and meningeal primary) melanoma
GNAS/GNAQ
Mitochondrial inheritance patterns
Classically mother-offspring, but actually can follow any pattern due to contribution of nuclear DNA to mitochondria.
Heteroplasmy
Uneven distribution of mitochondria in maternal transmission.
Trinucleotide repeats - Inheritance patterns
Mostly autosomal dominantMinority autosomal recessive (Freidrich ataxia), X-recessive (fragile X - CGG/FMR1)
Angelman, Prader-Willi
Disorder arising from mutation in non-imprinted parental allele.Angelman: UBE3A gene, maternal mutation (paternal silent)Prader-Willi: “PW genes”, paternal mutation (maternal silent)
Blots
Southern - DNANorthern - RNAWestern - ProteinNote: Southern blotting is more sensitive than PCR for most applications.
PCR variations
rtPCR - For RNA amplificationqPCR - Quantitative real-time, for viral loads, mutational burdenNested - Two sets of primers, two amplifications, with intervening wash cycle to purify
Isothermal amplification methods
TMA: Use reverse transcriptase and RNA pol to cycle between RNA and DNA. Faster than PCR!
Karyotype G-banding
Stains A-T rich (gene poor) segments
Melt curve analysis
Identifies differences in G:C content, causing differences in denaturing temperature
Lung adenocarcinoma mutations
25% K-RAS20% EGFR (in-frame exon 19 deletion, exon 21 L858R, T790M - resistant to 1st-gens)5% ALK/RET/ROS rearrangements (crizotinib)
MGMT promoter methylation
Seen in CNS tumors, predicts response to alkylating chemotherapy (TMZ, carmustine)
MDS - Genetics
Favorable: -Y, del(20q), del(11q), del(5q), normal karyotypeUnfavorable: Complex, -7
B-ALL genetics
Favorable: t(12;21) ETV6-RUNX1, hyperdiploidyUnfavorable: t(9;22), Ph-like, MLL-rearr (usually t(4;11)), hypodiploid, RUNX1 amplification
CLL genetics
Favorable: -13Unfavorable: -11q, -17p
Multiple myeloma genetics
Favorable: Hyperdiploidy (usually involves odd chromosomes other than 13)Unfavorable: Hypodiploidy, IGH rearrangements, complex karyotype
Abortive aneuplodies
Most common: 45,XOMost common trisomy: t16
K-RAS mutations
Virtually all are missense mutations of codons 12, 13, and 61.
Centromeric terminology
Acrocentric: Chromosome with centromere near end.Metacentric: Chromosome with central centromere.Submetacentric: Somewhere in between.Paracentric inversion: Does not involve centromere.Pericentric inversion: Does involve centromere.
Acral melanoma
KIT
IDH mutations
GAIN OF FUNCTION
Chromophobe RCC
Combined chromosomal losses: -1, -2, -6, -10, -13, -17
BCR-ABL transcripts
p190 (minor): Ph-like ALLp210 (major): CMLp230: CNL